Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients

Long-lasting success in lung cancer therapy using tyrosine kinase inhibitors (TKIs) is rare since the tumors develop resistance due to the occurrence of molecularly altered subclones. The aim of this study was to monitor tumors over time based on the quantity of mutant plasma DNA and to identify ear...

Descripción completa

Detalles Bibliográficos
Autores principales: Riediger, Anja Lisa, Dietz, Steffen, Schirmer, Uwe, Meister, Michael, Heinzmann-Groth, Ingrid, Schneider, Marc, Muley, Thomas, Thomas, Michael, Sültmann, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027592/
https://www.ncbi.nlm.nih.gov/pubmed/27640882
http://dx.doi.org/10.1038/srep33505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027592/
https://www.ncbi.nlm.nih.gov/pubmed/27640882
http://dx.doi.org/10.1038/srep33505

Ejemplares similares